Nuclear Medicine
Professor & Head :
Overview
The clinical practice of Nuclear Medicine involves administration of small amount of compounds labeled with radioactivity (radioactive isotopes) that are used to provide diagnostic information & also used for therapeutic purposes in a wide range of diseases. Nuclear Medicine facilities involve mainly two diagnostic modalities, SPECT i.e Single Photon Emission Computed Tomography and PET/CT i.e Positron Emission Tomography coupled with Computed Tomography.
The Department of Nuclear Medicine in Tata Memorial Centre was started in December 2004 with the inauguration of India’s first PET/CT scanner coupled with 16 slice CT. This was soon followed by installation of a dedicated PET/CT scanner in ACTREC Campus in January 2015 which has consistently catered to lakhs of cancer patients for more than two decades by aiding in their accurate diagnosis. With a purpose of providing comprehensive cancer care to all through our motto of Excellence in service, research and education, Dept. of Nuclear Medicine is all set to expand its work in the recently commissioned Radiological Research Unit Facility (RRU). This state-of-the-art facility has one extended field-of-view PET/CT and one Digital PET CT scanners, three SPECT scanners, and 41 inpatient isolation therapy beds (radioisotope therapy ward), making it one of the world's largest Nuclear Medicine facilities.
Our department is equipped with three Gamma camera SPECT scanners which provide a wide range of scans enlisted below.
- Brain Scintigraphy
- Salivary Scintigraphy
- Thyroid & parathyroid Scintigraphy
- Lung perfusion Scintigraphy
- Cardiac Scintigraphy
- Gastrointestinal & Hepatobiliary Scintigraphy
- Renal Scintigraphy
- Sentinel node imaging
- Lymphoscintigraphy
- Bone Scintigraphy
We have a dedicated Radiopharmacy lab in which various novel radiopharmaceuticals are labeled and studied as service as well as in an approved trial setting. Additionally, our Bio Imaging Facility, featuring three cutting-edge animal scanners, supports pre-clinical research that accelerates the development of new cancer therapies, bringing us closer to breakthrough treatments
Theranostics in Nuclear Medicine is a unique approach which utilizes a pair of diagnostic and therapeutic agents that share a common target on tumor sites. Precise treatment of the disease with minimum side effects is the principal aim of theranostics.
We have a well-structured Theranostics programme which includes Radioactive Iodine treatment for Thyroid cancers, PSMA radioligand based therapies for prostate cancers and PRRT for cancers of neuroendocrine origins, medullary carcinoma of thyroid and meningioma, and Yttrium based Trans-arterial Radioembolization (TARE) for hepatocellular carcinomas.
More than 300 patients per year are being catered with various radionuclide targeted therapies in our department. With recent commissioning of a 41 bedded radiation safety ward, our department is all set and committed to provide quality care to the patients with advanced targeted radionuclide therapies, thus making it one of the finest centers of excellence for Nuclear Medicine in the country.
The Department provides comprehensive training to the Post Graduate residents pursuing MD course in Nuclear Medicine through didactic lectures, seminars, journal clubs. Resident Doctors are posted in various diagnostic setups like SPECT, PET/CT, radiopharmacy along with radiation safety ward. Each student is given a dissertation topic and is mentored throughout their residency program. Student’s competency in the field of Nuclear Medicine is tested in a timely manner by conducting theory and practical examinations in concordance with the guidelines laid down by Homi Bhabha National Institute University.
Department also has a Master of Science in Nuclear Medicine (MSc Nuclear Medicine), which is a two year post graduate training program affiliated to Homi Bhabha National Institute.
Fellowship Program in Theranostics
Recently, a dedicated Fellowship Program in Theranostics is also introduced. This specialized program focuses on the integration of targeted radionuclide therapy and diagnostic imaging, providing participants with hands-on experience in the latest Theranostics techniques. Fellows will gain in-depth knowledge and skills in the personalized treatment of various cancers and other diseases using advanced radiopharmaceuticals.
ACTREC, which is a state-of-the-art Research wing of Tata Memorial Center, is built with a vision of providing cutting edge research in the field of cancer care. Dept. of Nuclear Medicine is also committed to provide relevant and affordable diagnostic and therapeutic services with help of developing innovative radiopharmaceutical agents. It also emphasizes on promoting clinical research methodology programmes with the focus on improving the knowledge of fundamental research with the development of systematic protocols and their execution.
 | Dr. Venkatesh Rangarajan |
 | Dr. Archi Agrawal |  | Dr Sayak Choudhury |
 | Dr. Suchismita Ghosh |
 | Dr. Indraja Dev |
 | Dr. Dr Manikandan M.V. |
 | Mrs. Pooja Dwivedi |
 | Mr. Dinesh Rawat |
 | Mr. Sunit Mitra |
 | Mr. Dibyapraksh |
 | Mrs. Sarika Paunikar |
 | Mr. Viraj Sawant |
 | Mr. Vishal Vajarkar |
 | Mr. Karan Tanwar |
 | Mr. Manoj Kumar Chauhan |
 | Mr. Vivekanand Dubey |
 | Mr. Abdul Shaikh |
 | Mrs. Renuka Pawar |
 | Mrs. Kranti Khairnar |
 | Ms. Jennit Ittiachan |